Drug
Black Seed Oil Extract Supplement clinical trials
- studies test it
- 10
- open now
- 1
- in phase 3
- 2
- first study started
- 2008
Keep track of what changes. Save the Black Seed Oil Extract Supplement studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Combined with it in one product
Studies by the year they started
10 studies that test it; most in 2009 (3)
| Year | Studies |
|---|---|
| 2008 | 2 |
| 2009 | 3 |
| 2019 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2025 | 1 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 6
- Phase 2
- 1
- Phase 3
- 2
- No phase
- 1
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 6 · Other 4
NuPathe Inc. (5) · Amr Mohamed MD (1) · Ramsar international campus (1) · M.D. Anderson Cancer Center (1) · Novatek Pharmaceuticals (1) · University of Florida (1)
Often tested with
Tested in the same studies.
Nigella sativa oil (8) · Sumatriptan (5) · Nivolumab (1) · Ipilimumab (1)
Studies
Open first, then newest update. How each study uses Black Seed Oil Extract Supplement is read from its arms, and is right about nine times in ten.
Testing it · 10
- Phase 1 Dose Escalation and Dose Expansion Trial of NP-101 in Patients With Solid TumorsRecruitingPhase 1M.D. Anderson Cancer CenterNCT06563375Written as NP-101
- Study of the Safety, Tolerability and Efficacy of NP-101 in Treating High Risk Participants Who Are Covid-19 Positive.TerminatedPhase 2Novatek PharmaceuticalsNCT05785390Written as NP-101
- NP-101 (TQ Formula) With Nivolumab and Ipilimumab in Advanced or Metastatic Extra-pulmonary Neuroendocrine CarcinomasCompletedPhase 1Amr Mohamed MDNCT05262556Written as NP-101 (TQ Formula)
- Study of NP-101 in Patients With Unresectable Hepatocellular Carcinoma (HCC) Undergoing Y-90 TreatmentWithdrawnPhase 1University of FloridaNCT06217094Written as NP-101 (3 g)
- Black Seed Oil in Treatment of OsteoarthritisCompletedNot applicableRamsar international campusNCT06029868Written as Black seed oil capsule
- Compare PK and Bioavailability of 2 NP101 Patches With Oral Imitrex in Healthy AdultsCompletedPhase 1NuPathe Inc.NCT01381796Written as NP101
- An Open-Label Study to Evaluate the Safety of NP101 in the Treatment of Acute Migraine Over Twelve MonthsCompletedPhase 3NuPathe Inc.NCT00806546Written as NP101
- An Open-Label Study to Evaluate the Safety of NP101 in the Treatment of Acute Migraine Over 12 MonthsCompletedPhase 3NuPathe Inc.NCT00792103Written as NP101
- Phase I Open Label Single-Dose Study to Compare the Pharmacokinetics of NP101 Healthy VolunteersCompletedPhase 1NuPathe Inc.NCT00720018Written as NP101 Sumatriptan Iontophoretic Transdermal Patch
- Phase I, Open Label, Single-Dose, Four Way Crossover Study to Compare the PK of NP101 With Oral Imitrex® (50mg) in Migraine Subjects During an Acute Migraine Attack and During a Non-Migraine PeriodCompletedPhase 1NuPathe Inc.NCT00723983Written as NP101 Study Patch